A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases.

Naohiko Nakamura Shinichi Kinami Yoritaka Fujii Seiko Miura Jun Fujita Daisuke Kaida Yasuto Tomita Takashi Miyata Hideto Fujita Nobuhiko Ueda Takeo Kosaka

Published in: Clinical case reports (2019)

When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.

Keyphrases

locally advanced
metastatic breast cancer
neoadjuvant chemotherapy
squamous cell carcinoma
rectal cancer
phase ii study
epidermal growth factor receptor
radiation therapy
small cell lung cancer
metastatic colorectal cancer
phase iii
emergency department
early onset
tyrosine kinase
clinical trial
open label